Alcami, a global pharmaceutical CDMO, has appointed Patrick D. Walsh as chairman and chief executive officer, effective immediately. He succeeds Walter J. Kaczmarek III, who is stepping down as chief executive.
Alcami, a global pharmaceutical contract development and manufacturing organization (CDMO), announced that its Board of Directors has appointed Patrick D. Walsh as Chairman and Chief Executive Officer, effective immediately.